VIRPAX Trademark

Trademark Overview

On Friday, December 2, 2022, a trademark application was filed for VIRPAX with the United States Patent and Trademark Office. The USPTO has given the VIRPAX trademark a serial number of 97701565. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 19, 2024. This trademark is owned by Virpax Pharmaceuticals. The VIRPAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain and CNS disorders
virpax

General Information

Serial Number97701565
Word MarkVIRPAX
Filing DateFriday, December 2, 2022
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pain and CNS disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVirpax Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerwyn, PA 19312

Trademark Events

Event DateEvent Description
Tuesday, December 6, 2022NEW APPLICATION ENTERED
Wednesday, December 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 11, 2023ASSIGNED TO EXAMINER
Wednesday, September 13, 2023NON-FINAL ACTION WRITTEN
Wednesday, September 13, 2023NON-FINAL ACTION E-MAILED
Wednesday, September 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, January 2, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, January 2, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, January 10, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 10, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, January 10, 2024PETITION TO REVIVE-GRANTED
Wednesday, January 10, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, January 10, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, July 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 4, 2024ASSIGNED TO LIE
Thursday, September 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 19, 2024NON-FINAL ACTION E-MAILED
Thursday, September 19, 2024NON-FINAL ACTION WRITTEN

Related Keywords

virpax disorders pain treatment preparations pharmaceutical